Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum [Yahoo! Finance]
Autonomix Medical, Inc. (AMIX)
Company Research
Source: Yahoo! Finance
The Octane Medical Innovation Forum brings together industry experts, entrepreneurs, investors and thought leaders for two days of learning, networking and innovation on the latest insights and trends in the medical industry. For more information, visit the event website here As part of the podium presentation, Brad Hauser, Chief Executive Officer of Autonomix, will discuss the latest developments in Autonomix's minimally invasive nerve-sensing, ablation and verification platform technology that has the potential to address a number of disease categories from chronic pain management to hypertension and cardiology. The Company's first-in-class technology platform utilizes a catheter-based microchip sensing array antenna that has the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. Once target nerves are identified, Autonomix uses its proprietary radio frequency (RF) ablation technology to kill targ
Show less
Read more
Impact Snapshot
Event Time:
AMIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMIX alerts
High impacting Autonomix Medical, Inc. news events
Weekly update
A roundup of the hottest topics
AMIX
News
- Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering [Yahoo! Finance]Yahoo! Finance
- Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public OfferingGlobeNewswire
- Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate UpdateGlobeNewswire
- Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain ReductionGlobeNewswire
- Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical TrialGlobeNewswire
AMIX
Sec Filings
- 11/12/24 - Form S-1/A
- 11/12/24 - Form 8-K
- 11/8/24 - Form 10-Q
- AMIX's page on the SEC website